Carillon Eagle Mid Cap Growth Fund

880 Carillon Parkway,Building 6
St. Petersburg , FL, 33716

Rank

Rank Universe

Summary

The fund seeks capital appreciation by investing in mid-size companies in the United States.

The investment process starts with companies in the benchmark index and is designed to highlight with above-average earnings growth outlook.

The team uses fundamental analysis to identify companies with a positive catalyst for growth, such as a new product, acquisition, divestiture, restructuring or change in the marketplace. The team also evaluates the roles and capabilities of management.

The fund invests across variou

Link

Directors

Mar 12, 2024
  • Liana Marante
  • Krishna K. Memani
  • Keith B. Jarrett
  • John Carter
  • Jerry A. Webman
  • Deborah L. Talbot

Chief Compliance Officer

  • Ludmila Chwazik

Price

  • $83.01 ( +0.05 ) Nov 1, 2024 Last Close
  • Net Assets
  • $6.5B
    Feb 26, 2024
    More
  • 52-Week High/Low
  • $0 - $0
  • Turnover
  • 32%
  • Expense Ratio
  • 0.73%

Company Name

Holding

Cencora Inc 2 %
Baker Hughes Co 1.88 %
Ares Management Corp 1.64 %
Booz Allen Hamilton Holding Co 1.64 %
Axon Enterprise Inc 1.55 %
Antero Resources Corp 0.93 %
Align Technology Inc 0.86 %
Carlyle Group Inc/The 0.79 %
Alnylam Pharmaceuticals Inc 0.71 %
BioMarin Pharmaceutical Inc 0.65 %
More

Documents

Prospectus

Annual Reports

Performance

YTD

5.5%

3 Year

-26.02%

5 Year

22.49%

Best

40.44%

2009

Worst

-26.57%

2022

Alpha

HAGIX Russell Midcap

Chart +